Innovation
Army signs a prototype agreement worth up to $4.8M with Sunflower Therapeutics PBC.
What the record says
Bring ruggedized sunflower therapeutics daisy petal system from TRL 04 to TRL 07 for manufacture of protein-based medical countermeasures in support of the warfighter (primarily in remote or austere environments). $1K obligated at signing on Apr 10, 2026; $4.8M if all options are used. Runs to May 31, 2029. Published in FPDS this month.
- with all options
- $4.8M
- Stage
- Newly published
- Date
- Apr 10, 2026
From the record
- What it is for
- Bring ruggedized sunflower therapeutics daisy petal system from TRL 04 to TRL 07 for manufacture of protein-based medical countermeasures in support of the warfighter (primarily in remote or austere environments)
- Obligated at signing
- $1K
- With all options
- $4.8M
- Runs to
- May 31, 2029
- Base agreements this performer holds in FPDS
- 2
Who is involved
- Sunflower Therapeutics PBCPerformer
- Department of the Army (ACC-APG)Agency
Source: FPDS · Apr 10, 2026
What is not known yet
What the prototype has to demonstrate, and whether a follow-on production award will come.
Ask Intel
Source-backedWhy this is here: Prototype and production agreements are where new programs start. Published because: An other transaction agreement newly published in FPDS: base award, $1M+, signed within 12 months, performer not a consortium manager.